Wet AMD 5 Symposium

Related

• 

  Suprachoroidal Delivery of RGX-314 for Neovascular AMD: Initial Results From the Phase II AAVIATE Study

  Mark R. Barakat, MD

  Annual Meeting Talks

  2021

• 

  Real World Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study

  Carl J Danzig, MD

  Updates from the Field

  2022

• 

  ENVISION Trial 24-Week Data: Phase 2 Study of UBX1325, a New Senolytic Agent for Patients With Wet AMD

  Raj K. Maturi, MD

  Annual Meeting Talks

  2023